The use of cell models in determining neuronal responses to EASs - - PowerPoint PPT Presentation

the use of cell models in determining neuronal responses
SMART_READER_LITE
LIVE PREVIEW

The use of cell models in determining neuronal responses to EASs - - PowerPoint PPT Presentation

The use of cell models in determining neuronal responses to EASs Professor Robert A. Smith School of Life Sciences University of Glasgow Scotland (UK) Nervous System Complexity CNS and PNS Cellular


slide-1
SLIDE 1

The use of cell models in determining neuronal responses to EASs

Professor Robert A. Smith School of Life Sciences University of Glasgow Scotland (UK)

slide-2
SLIDE 2

Nervous System Complexity

  • CNS and PNS
  • Cellular heterogeneity

Neuronal and glial cells

Synaptic contacts/neural networks

  • Functional diversity

Regional specialisation Blood Brain Barrier Motor/sensory pathways Cognitive

  • Age Related susceptibility

Developmental stages Maturation after birth Adult

  • Acute/Chronic/Delayed Responses
slide-3
SLIDE 3

Brain Vulnerability…

  • Potentially more susceptible to damage by

hazardous chemicals (including EASs)

  • high metabolic rate
  • consumes more oxygen than other tissues.
  • Reactive Oxygen Species (ROS) generated
  • mitochondrial dysfunction
  • over activation of glutamate receptors

(especially NMDA receptors)

  • leads to Ca2+ influx
  • cell death pathways triggered
slide-4
SLIDE 4

The Developing Brain: Additional challenges…

  • Blood Brain Barrier incomplete
  • Cell proliferation/ neurogenesis
  • Cell migration

Neuronal cell differentiation

  • axon
  • dendrites
  • receptors

■ adrenergic, cholinergic, dopaminergic ■ -TH, estrogen and androgen

  • synaptogenesis
  • Glial maturation
slide-5
SLIDE 5

Neural targets of Endocrine Disruptors in vivo

Sex steroids and hormones crucial in developing brain

  • Hypothalamus
  • Pituitary
  • Hippocampus
  • Cerebral Cortex
  • Cerebellum

Control of Hypothalamic/neuroendocrine axis Spatial cognitive functions Memory Effects of: Insecticides - DDT (estrogen agonist) Polychorinated biphenyls (TH receptors) Phthalates (androgen antagonists)

slide-6
SLIDE 6

Neurotoxicity Testing Alternatives - Initiatives

Early

  • 31st OHOLO Conference: Model systems in neurotoxicology:

alternative approaches to animal testing (1986)

– Israel

Shahar & Goldberg, 1987

  • ECVAM Workshop: In vitro neurotoxicity testing – Italy

Atterwill et al., 1994

  • WHO/IPCS: In vitro techniques for assessing neurotoxicity (1997) – USA

Harry et al., 1998

Recent 3rd Intl Conference on Alternatives for DNT (2011) – Italy Bal-Price et al., 2012 Xi’an International Neurotoxicology conference (2011) – China

Llorens et al., 2012

  • Developmental neurotoxicity testing (2011)

– Japanese Teratology Society

Crofton et al., 2012

10th Intl Early Toxicity Screening conference (2012)

– USA

Neurotoxicity (opening session)

slide-7
SLIDE 7

In Vitro endpoints for predicting and assessing neurotoxicity

Cell proliferation Cell death Migration assays Neurite outgrowth/ network formation Protein marker expressions

  • Axonal
  • Dendrtic
  • Synaptic
  • Glial cell

Receptor expression

slide-8
SLIDE 8

In vitro systems available for determining neural responses

Continuous and immortalised cells lines

  • rodent/human
  • undifferentiated/differentiated

Primary neurons

  • mainly rodent

Brain slices

  • e.g. hippocampus

Stem and Progenitor cells

  • rodent/human
  • embryonic/induced pleuripotent

Adherent cultures or 3D floating neurosphere masses

slide-9
SLIDE 9

Cell Lines - Rodent

PC12 – rat pheochromocytoma (dopaminergic)

Undifferentiated - proliferation Differentiated

  • neurite outgrowth
  • Bisphenol-A (BPA) – neurites suppressed (Radio & Mundy, 2008)
  • BPA inhibited MAPK phosphorylation

(Seki et al., 2011)

B35 – rat neuroblastoma (cholinergic)

  • exposure to tetrabromo-BPA – ROS production, [ Ca2+]i

and caspase-3 activity increased

(Hendriks et al., 2012)

NB2a – mouse neuroblastoma (cholinergic)

  • neurite outgrowth

(Axelrad et al., 2003)

GH3 – rat pituitary

  • BPA induced Growth Hormone release (Dang et al., 2007; 2009)

C17.2 –

mouse cerebellum derivation

(Lunqvist et al., 2012)

slide-10
SLIDE 10

However, majority established from tumours…

Limitation of Continuous Cell Lines

slide-11
SLIDE 11

Primary cultured neurons

Cerebral cortex

Silva et al. (2006) Suňol et al. (2008) Briz et al. (2011)

Hippocampus

Matsunaga et al. (2010)

Cerebellum

  • Granule cells

Mundy et al. (2006) Suňol et al. (2008) Smith (2009) Briz et al. (2011)

  • Purkinje cells

Xiong et al. (2012)

Hypothalamus

Iwakura et al. (2010)

slide-12
SLIDE 12

Primary cultured rodent cerebellar granule cells

Homogeneous neuronal cultures Prepared from post-natal pups Functional glutamate receptors by 6-8 div Functional estrogen receptors Extensive neurite production

  • quantitative analysis of changes

Expression of neurotypic proteins

  • cytoskeleton
  • growth cones
  • synapses

Basis of many neurotoxicity studies

(Mundy et al., 2008; Bal-Price et al., 2010; Briz et al., 2011)

slide-13
SLIDE 13

Still in search of the Human Dimension…

Advantages of primary neurons over using cell lines established from tumours therefore -

  • More normal functional phenotype

BUT… Culture preparation with potential variability Relatively low-medium throughput screening Majority not of human origin

slide-14
SLIDE 14

Human Cell Lines

NTera-2 – teratocarcinoma (cholinergic)

Paquet-Durand et al. (2003)

  • Differentiated cells express neuronal polarity markers

Human origin but

  • lack advantage of 1˚ cultures
  • derived from tumours

Cell membrane potential assay - AcuteTox project chemicals

Gustafsson et al. (2010)

SH-SY5Y – neuroblastoma (dopaminergic) cells

Undifferentiated Differentiated Sanfeliu et al. (1999) Cheung et al. (2009) Tuj-1

Phase 40X Phase 40X

Neurite outgrowth and network formation assays

Frimat et al. (2010); van Thriel et al. (2012)

slide-15
SLIDE 15

LUHMES cells (NPCs from female fetal brain) Neurite quantification in live cells

(Stiegler et al., 2011)

HUB-NSC (Human umbilical cord derived)

(Buzanska et al., 2005)

Human Neural Crest Cells

(Generated from embryonic line)

(Zimmer et al., 2012)

Induced Neuronal Cells

(Conversion of fetal and postnatal fibroblasts)

(Pang et al., 2010)

The way forward…. Human Neural Stem Cells

Immortalised stem cells (fetal brain)

hNSC

(De Filippis et al., 2007)

ReNcell CX

(Breier et al, 2008)

Neuronal Precursor Cells

PCBs disrupt TH-dependent

(Fritsche et al., 2005;

neural & glial differentiation

Schreiber et al., 2010)

slide-16
SLIDE 16

The Neurosphere Assay for Developmental Neurotoxicity Testing

Human (or Rodent) Fetal NPCs Proliferation -

* Quantify by several methods

Migration –

* NPCs leave sphere following growth factor withdrawal

Differentiation –

* Neuronal & glial markers

  • Tuj-1 (green)
  • O4 (red)

Breier et al. (2010): Neurotox. Teratol. 32: 4-15

slide-17
SLIDE 17

Polybrominated Diphenyl Ethers inhibit differentiation of hNPCs

Schreiber et al. (2010): Environ Health Perspect 118, 572-578

Control 10 µM PBDE- 47 10 µM PBDE- 99 Tuj-1 O4

Migration and differentiation of neurons and oligodendrocytes reduced following exposure to PBDEs

slide-18
SLIDE 18

HUCB-NSC – Buzanska Lab

Zychowicz et al. (2011): Acta Neurobiol. Exp. 71, 12-23

ECM bioengineered printed arrays

+ 2% Serum Serum free PLL FN Tuji-1: green Ki-67 (proliferation): red Hoechst: nuclei

Culture environment effect - PLL – undifferentiated FN – differentiated Incorporate electrodes Potential in neurotoxicity screens

proliferation differentiation migration neurite outgrowth electrophysiology

slide-19
SLIDE 19

hESC-derived NC cells used in MINC assay

Used to assay migration impairment

  • f NC cells (MINC)

following exposure to chemicals

Zimmer et al. (2010): Environ. Health Perspect. 120, 1116-1122

Untreated Treated

Tuj-1 Peripherin DNA Tuj-1 Brn3a Tuj-1 NeuN

Peripheral markers expressed in neural cells from hESC

slide-20
SLIDE 20

Other promising approaches

  • Genomic and metabolomic analyses

Gene expression changes in murine NSCs following chemical exposure Need define thresholds between adaptive v. adverse responses

(Pennings et al., 2012; Theunissen et al., 2012)

  • Neuronal cells from fetal & postnatal fibroblasts

Transgene activation and transcription factor induction

(Pang et al., 2011; Kumar et al., 2012)

Mathematical & computational initiatives

ToxCast Programme (EPA)

slide-21
SLIDE 21

Unresolved Issues…

In vitro methods unable to mimic complexity of brain Yet to achieve brain-region specific human neural cells Cognitive and behavioural aspects Selection of appropriate battery of neurotoxicity tests Validation Routine High Throughput Screening

slide-22
SLIDE 22

Current State of the Available Art…

Evolution of neural cell models for neurotoxicity Exciting advances in human cell technologies

– stem and NPCs of particular merit

Reliable endpoints for testing neurotoxicity (incl. DNT)

– proliferation – migration – neurite outgrowth – functional activity

Data on mechanisms of action Relevance to investigation of responses to EASs